Who is sponsoring NCT05031091?

NCT05031091 is sponsored by Centre Hospitalier de Cayenne.

What drugs are being tested in NCT05031091?

Interventions in NCT05031091: standardised exposure questionnaire.

What condition does NCT05031091 study?

NCT05031091 studies Hansen's Disease.

Is NCT05031091 still recruiting?

NCT05031091 is currently status unknown. Last updated 1 September 2021.

Last reviewed 2021-09-01 · How we verify

NCT05031091: EPI-LEPR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiology of Leprosy in French Guiana

Status unknown Last updated 1 September 2021

What this trial tests

trial testing standardised exposure questionnaire in Hansen's Disease in 368 participants. Status unknown.

Timeline

7 January 2020

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Centre Hospitalier de Cayenne
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	368
Start date	7 January 2020
Primary completion	31 December 2022
Estimated completion	31 December 2023
Sites	1 location across French Guiana

Drugs / interventions tested

standardised exposure questionnaire

Conditions studied

Hansen's Disease — all drugs for Hansen's Disease →

Sponsor

Centre Hospitalier de Cayenne

Who can join

Eligibility, any sex, with Hansen's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the present study is the genotyping of M. leprae strains found in leprosy patients in French Guiana. The secondary objectives are to investigate the presence of M. lepromatosis in these patients, the molecular research of M. leprae resistance to anti-leprosy antibiotics, the study of risk factors for leprosy in humans in Guyana and in particular direct or indirect contact with armadillos, as well as the determination of phylogenetic links between the M. leprae strains found in French Guiana, and with the regional and world reference strains Epidemiology of leprosy in French Guiana.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier de Cayenne trials

Trials by the same sponsor.

NCT06543875 — Overweight, Obesity and Weight Variation Among Incarcerated Women in French Guiana: a Study of Factors Associated With W · completed
NCT06065553 — Prevalence of Psychiatric and Substance Abuse Disorders Among People in Precarious Situations in Cayenne · recruiting
NCT06095076 — Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc) · unknown
NCT05814068 — Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the I · NA · unknown
NCT06692985 — Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vector · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05031091 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Cayenne
Last refreshed: 1 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05031091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing